Clinical Trial Update: Ultralow Dose PET Imaging for 18F-NaF Uptake [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ultralow-dose PET imaging with 18F-NaF uptake in healthy volunteers and individuals with bone or joint conditions; recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Bone Cancer
• Osteoarthritis
• Osteomyelitis
• Septic Arthritis

Drugs mentioned

• Fluorine-18 sodium fluoride (18F-NaF) (18F-sodium fluoride)

Snippet

Sponsor: Akiva Mintz | Conditions: Healthy Volunteer, Bone Alteration | Phase 2 | Status: RECRUITING